Prevail Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
NEW YORK, Sept. 18, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based […]